[HTML][HTML] The serum galectin-3 levels are associated with the severity and prognosis of ischemic stroke

JJ Zhuang, L Zhou, YH Zheng, YS Ding - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
Abstract Galectin-3, a microglia/macrophage-derived inflammatory mediator, plays a role in
the stroke progression. In this single-center prospective study, we included 288 consecutive …

Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort

A Jagodzinski, AS Havulinna, S Appelbaum… - International Journal of …, 2015 - Elsevier
Objectives Galectin-3 is an emerging biomarker playing an important, complex role in
intracellular pathways of cardiovascular diseases and heart failure. We aimed therefore to …

Association of Galectin‐3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST‐Segment Elevation …

A Tymińska, A Kapłon-Cieślicka, K Ozierański… - Disease …, 2019 - Wiley Online Library
Purpose. To investigate the association of galectin‐3 (Gal‐3) and soluble ST2 (sST2) and
their follow‐up changes with the development of heart failure (HF) and echocardiographic …

Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22

EW Grandin, P Jarolim, SA Murphy… - Clinical …, 2012 - academic.oup.com
BACKGROUND Galectin-3 is a β-galactoside–binding lectin that has been implicated in
cardiac fibrosis and remodeling, is increased in models of failure-prone hearts, and has …

Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo …

LB Daniels, P Clopton, GA Laughlin, AS Maisel… - American heart …, 2014 - Elsevier
Background Galectin-3 is a marker of myocardial fibrosis that has been implicated in the
pathophysiologic pathway of fibrosis; its association with all-cause and cardiovascular …